BOWEN MICHAEL,DALL'ACQUA WILLIAM,JALLAL BAHIJA,WU HERREN,KIENER PETER A,COYLE ANTHONY,DALLACQUA WILLIAM
申请号：
ZA201207249
公开号：
ZA201207249B
申请日:
2012.09.27
申请国别(地区):
ZA
年份:
2013
代理人:
摘要：
The present invention provides human anti-IL-6 antibodies with extended in vivo half-life. The invention further relates to pharmaceutical compositions, therapeutic compositions, and methods using therapeutic antibodies that bind to IL-6 and that has an extended in vivo half-life for the treatment and prevention of IL-6 mediated diseases and disorders, such as, but not limited to, inflammatory diseases and disorders, autoimmune diseases and disorders and tumors.
